US 10828315
Targeted therapeutics
granted A61KA61K31/165A61K31/167
Quick answer
US patent 10828315 (Targeted therapeutics) held by Madrigal Pharmaceuticals, Inc. expires Mon Nov 05 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Madrigal Pharmaceuticals, Inc.
- Grant date
- Tue Nov 10 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 05 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 2
- CPC classes
- A61K, A61K31/165, A61K31/167, A61K31/416, A61K31/4184